UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
|
July
31, 2013 |
| Date of report (Date of earliest event reported) |
|
SurModics, Inc. |
| (Exact Name of Registrant as Specified in its Charter) |
|
Minnesota |
0-23837 |
41-1356149 |
||
|
(State of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.) |
|
9924 West 74th Street Eden Prairie, Minnesota |
55344 |
|
| (Address of Principal Executive Offices) | (Zip Code) |
|
(952) 500-7000 |
| (Registrant’s Telephone Number, Including Area Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 2.02 | Results of Operations And Financial Condition. |
On July 31, 2013, SurModics, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the results for the quarter ended June 30, 2013. A copy of the full text of the Press Release is furnished as Exhibit 99.1 to this report.
| Item 8.01 | Other Events. |
In the Press Release, the Company also announced that its Board of Directors has authorized the Company to repurchase up to $20 million of the Company’s outstanding common stock. Under the share repurchase program, repurchases may be effected through open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, tender offers, or by any combination of such methods. The share repurchase program does not have a fixed expiration date.
|
Item 9.01 |
Financial Statements and Exhibits. |
|||
|
(d) |
Exhibits. |
|||
|
Exhibit |
Description | |||
| 99.1 | Press Release dated July 31, 2013. | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SURMODICS, INC. |
|||
|
|
|||
| Date: | July 31, 2013 |
|
/s/ Andrew D. C. LaFrence |
|
Andrew D. C. LaFrence |
|||
|
Vice President Finance and Chief Financial Officer |
|||
EXHIBIT INDEX
| Exhibit | |
|
Number |
Description |
|
99.1 |
Press Release dated July 31, 2013 |